HIGHLIGHTS
- who: TACC et al. from the Center, Fourth Hospital of Medical University, Shijiazhuang, China have published the research: (Landmark Ed) 2022; 27(8): Abnormal Expression is an Independent Prognostic Biomarker in, in the Journal: (JOURNAL)
- what: The aim of this study was to investigate possible associations between tumor expression of and the clinicopathological characteristics and prognosis of patients. This study provides evidence that expression is upregulated in and may be an independent risk factor for worse prognosis in these patients. This study demonstrated a significant relationship between TACC3 expression and patient survival in LUAD.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.